1. O. V. Karachentseva, V. N. Yartsev, and D. P. Dvoretskii, “Noradrenaline facilitates the restoration of decreased neurogenic vasoreactivity,” Ros. Fiziol. Zh., 94, No. 1, 37–44 (2008).
2. O. V. Karachentseva, V. N. Yartsev, D. P. Dvoretskii, and I. V. Zhdanova, “Effects of melatonin on neurogenic vasoreactivity: conditions for the formation and modulation of vascular responses,” Ros. Fiziol. Zh., 89, No. 2, 146–153 (2003).
3. V. N. Yartsev and O. V. Karachentseva, “Contractile activity of isolated mesenteric artery perfused by solutions with different pH values,” Ros. Fiziol. Zh., 82, No. 8–9, 28–36 (1996).
4. V. N. Yartsev, O. V. Karachentseva, and D. P. Dvoretskii, “Effects of exogenous noradrenaline and melatonin on neurogenic vasoreactivity,” Ros. Fiziol. Zh., 90, No. 11, 1363–1369 (2004).
5. J. Akinaga, V. Lima, L. R. Kiguti, et al., “Differential phosphorylation, desensitization, and internalization of α1A-adrenoceptors activated by norepinephrine and oxymetazoline,” Mol. Pharmacol., 83, No. 4, 870–881 (2013).